Phase 1 Study of Zoledronic Acid in Sickle Cell Disease

Summary

The long-term goal of this study is to learn if Zoledronic Acid can prevent or reduce pain in sickle cell disease. The goal of this study is to learn about the safety of Zoledronic Acid in persons with sickle cell disease who experience chronic pain requiring medical treatment or use of narcotics.

Timeline

Start

2007-06

Primary completion

2008-05

Completion

2008-05

Drugs

Indications